Citrate moser will benefit (Mosapride Citrate, MC) promote power for the fourth generation of gastrointestinal medicine, is a potent selectivity of 5 - HT4 agonists, through 5 - excited myenteric plexus HT4 receptors, stimulate acetylcholine release, strengthen the stomach and duodenum movement, clinical used in functional dyspepsia, gastroesophageal reflux disease, diabetic gastroparesis, partial nephrectomy in patients with gastric diseases such as gastric dysfunction. Common adverse reactions include diarrhea, abdominal pain, dry mouth, rash, tiredness and headache. At present, its market products are only tablets, dispersible tablets, capsules and other oral dosage forms.